E. Rehman et al., “High Risk of Cardiovascular Events in Patients, Biosynthesis of Aspirin-Resistant Thromboxane And The Risk Of Stroke, Myocardial Infarction Or Death: Biosynthesis of Aspirin-Resistant Thromboxane & Risk of Stroke”, PBMJ, vol. 5, no. 6, pp. 213–218, Jun. 2022, doi: 10.54393/pbmj.v5i6.583.